OCRA
News & Updates
-
Ovarian Cancer Resources & Support
OCRA is committed to offering patients, caregivers and friends the most up to date information about ovarian cancer, helpful resources, and options for support…
-
New Research Shows Cervical Cells May Hold Key to Predicting Ovarian Cancer Risk
Cervical cell samples that are routinely collected as part of Pap smears may hold promise for predicting the risk of ovarian and other cancers, according to recent findings published as two separate…
-
Xueyang Yu, PhD., Ovarian Cancer Researcher | Meet a Scientist
Dr. Xueyang Yu, of Massachusetts Institute of Technology, is a 2021 recipient of OCRA’s Ann and Sol Mentored Investigator Award…
-
Our Community Needs YOU | Heroes Highlights
The ovarian cancer community is counting on a hero… and that OCRA Hero could be you! If you’re looking to do good in 2022, it can be as simple (and fun!) as turning your favorite…
-
Study Finds Pfizer-BioNTech COVID-19 Vaccine Safe and Effective for Gynecologic Oncology Patients
A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing…
-
PARP Inhibitors and Ovarian Cancer
Over the past decade, a new class of drugs called PARP inhibitors have been approved by the Food and Drug Administration (FDA) for use in ovarian cancer…
Help Save Women's Lives
Our Impact
-
Invested over $100M
in ovarian cancer research since 1998
-
Educated 95,000+
future medical professionals since 2002
-
Advocated for $200M+
in government research and education funding in 2019
Fundraise for OCRA
-
Do It Yourself
Create your own unique fundraiser to help end ovarian cancer.
-
Ovarian Cycle
Start or join an Ovarian Cycle® ride in your town and spin for a cure!
Check out our calendar for an upcoming event near you!